Literature DB >> 18358413

Central nervous system signs in X-linked Charcot-Marie-Tooth disease after hyperventilation.

Jayasri Srinivasan1, Richard J Leventer, Andrew J Kornberg, Henrik H Dahl, Monique M Ryan.   

Abstract

The X-linked Charcot-Marie-Tooth disease is the second most common form of inherited neuropathy and, unlike most other forms of this disease, may present with atypical manifestations because of central nervous system involvement. Episodic central nervous system symptoms in X-linked Charcot-Marie-Tooth disease may be triggered by illness, dehydration, physical exercise, or exposure to altitude. We describe a child with transient episodes of hemiplegia after simple hyperventilation, a presentation not previously described in pediatric Charcot-Marie-Tooth disease type X.

Entities:  

Mesh:

Year:  2008        PMID: 18358413     DOI: 10.1016/j.pediatrneurol.2007.12.003

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  12 in total

1.  The role of gap junctions in Charcot-Marie-Tooth disease.

Authors:  Kleopas A Kleopa
Journal:  J Neurosci       Date:  2011-12-07       Impact factor: 6.167

Review 2.  Gap junctions in inherited human disorders of the central nervous system.

Authors:  Charles K Abrams; Steven S Scherer
Journal:  Biochim Biophys Acta       Date:  2011-08-16

3.  A novel GJB1 frameshift mutation produces a transient CNS symptom of X-linked Charcot-Marie-Tooth disease.

Authors:  Hideya Sakaguchi; Satoshi Yamashita; Akiko Miura; Tomoo Hirahara; En Kimura; Yasushi Maeda; Tadashi Terasaki; Teruyuki Hirano; Makoto Uchino
Journal:  J Neurol       Date:  2010-09-21       Impact factor: 4.849

4.  A start codon CMT1X mutation associated with transient encephalomyelitis causes complete loss of Cx32.

Authors:  Irene Sargiannidou; Gun-Ha Kim; Styliana Kyriakoudi; Baik-Lin Eun; Kleopas A Kleopa
Journal:  Neurogenetics       Date:  2015-03-15       Impact factor: 2.660

5.  Structural and functional brain changes in X-linked Charcot-Marie-Tooth disease: insights from a multimodal neuroimaging study.

Authors:  Georgios Koutsis; Georgios Velonakis; Efstratios Karavasilis; Foteini Christidi; Eirini Pantou; Georgia Angelopoulou; Dimitrios Kasselimis; Marianthi Breza; Zoi Kontogeorgiou; Dimitrios Filippiadis; Constantin Potagas; Georgia Karadima
Journal:  Neuroradiology       Date:  2021-09-09       Impact factor: 2.804

6.  CNS involvement in CMTX1 caused by a novel connexin 32 mutation: a 6-year follow-up in neuroimaging and nerve conduction.

Authors:  Chong Xie; Xiajun Zhou; Desheng Zhu; Wei Liu; Xiaoqing Wang; Hong Yang; Zezhi Li; Yong Hao; Guang-Xian Zhang; Yangtai Guan
Journal:  Neurol Sci       Date:  2016-04-20       Impact factor: 3.307

7.  A new mutation in GJC2 associated with subclinical leukodystrophy.

Authors:  Charles K Abrams; Steven S Scherer; Rafael Flores-Obando; Mona M Freidin; Sarah Wong; Eleonora Lamantea; Laura Farina; Vidmer Scaioli; Davide Pareyson; Ettore Salsano
Journal:  J Neurol       Date:  2014-07-25       Impact factor: 4.849

8.  Systemic inflammation disrupts oligodendrocyte gap junctions and induces ER stress in a model of CNS manifestations of X-linked Charcot-Marie-Tooth disease.

Authors:  Margarita Olympiou; Irene Sargiannidou; Kyriaki Markoullis; Christos Karaiskos; Alexia Kagiava; Styliana Kyriakoudi; Charles K Abrams; Kleopas A Kleopa
Journal:  Acta Neuropathol Commun       Date:  2016-09-01       Impact factor: 7.801

9.  Hyperventilation Increases the Randomness of Ocular Palatal Tremor Waveforms.

Authors:  Wanchat Theeranaew; Hyo-Jung Kim; Kenneth Loparo; Ji-Soo Kim; Aasef G Shaikh
Journal:  Cerebellum       Date:  2021-10       Impact factor: 3.847

Review 10.  Connexinopathies: a structural and functional glimpse.

Authors:  Isaac E García; Pavel Prado; Amaury Pupo; Oscar Jara; Diana Rojas-Gómez; Paula Mujica; Carolina Flores-Muñoz; Jorge González-Casanova; Carolina Soto-Riveros; Bernardo I Pinto; Mauricio A Retamal; Carlos González; Agustín D Martínez
Journal:  BMC Cell Biol       Date:  2016-05-24       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.